Izabela Sumara, winner of Sanofi's new European academic partnership program
July 10, 2018
The Sanofi innovation Awards program in Europe is helping to establish new early stage research approaches that can quickly translate innovative academic research into clinical testing, with the potential to have a significant impact on patients
A three-year program to invest a total of up to 6 million euros in funding innovative research projects across academic centers in France and Germany
This year, nineteen academic projects selected by an Academic and Sanofi Joint Steering Committee, among 190 dossiers submitted
Paris, Frankfort, June 29, 2018 - Sanofi announces today that it has recognized 19 innovative research projects as part of the new Sanofi Innovation Awards Europe program (Sanofi iAwards Europe). This first of its kind, stepping-stone initiative brings together multiple academic research institutions as partners at the earliest stages of drug discovery and expertise sharing, to prepare for possible multi-year research collaboration for the most promising projects.
The program’s academic partners initially include leading research institutions in France and in Germany, with academic centers from other European countries expected to join in future years.
The Sanofi iAwards program seeks to promote potential scientific breakthroughs, especially through the exchange of knowledge between Sanofi and top academic scientific teams. It will fund and nurture selected academic projects for one year, with the potential to lead to further collaborations. The aim is to accelerate the research and development process and address patients’ needs more quickly. These efforts combine new learnings from academic institutions on the biological mechanisms of diseases, and Sanofi’s drug discovery and development capabilities. Sanofi launched this annual program in Europe for a period of three years.
A Sanofi iAwards Europe ceremony has been held in june in Paris, with participating French and German academic centers, recognized project leaders and Sanofi Research & Development (R&D) teams.
Izabela Sumara's project at IGBMC on breast, colorectal and pancreatic cancers is one of 19 selected projects.